Heavy charged particle radiobiology: Using enhanced biological effectiveness and improved beam focusing to advance cancer therapy

Department of Environmental and Radiological Health Sciences, Colorado State University, Ft. Collins, CO 80523, USA.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (Impact Factor: 4.44). 03/2011; 711(1-2):150-7. DOI: 10.1016/j.mrfmmm.2011.02.012
Source: PubMed

ABSTRACT Ionizing radiation causes many types of DNA damage, including base damage and single- and double-strand breaks. Photons, including X-rays and γ-rays, are the most widely used type of ionizing radiation in radiobiology experiments, and in radiation cancer therapy. Charged particles, including protons and carbon ions, are seeing increased use as an alternative therapeutic modality. Although the facilities needed to produce high energy charged particle beams are more costly than photon facilities, particle therapy has shown improved cancer survival rates, reflecting more highly focused dose distributions and more severe DNA damage to tumor cells. Despite early successes of charged particle radiotherapy, there is room for further improvement, and much remains to be learned about normal and cancer cell responses to charged particle radiation.

Download full-text


Available from: Jac Nickoloff, Nov 13, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mg2BO3F:Dy phosphor is a low Z material with an effective atomic number 9.92. This phosphor was synthesized by two different methods, because the solid state method failed to produce single phase Mg2BO3F:Dy phosphor. This study reports a comparative investigation of γ-ray and C5+ ion beam impact on thermoluminescence (TL) properties of Mg2BO3F:Dy phosphor. TRIM/SRIM calculations were performed to correlate the changes in TL properties of Mg2BO3F:Dy phosphor. Phosphor possesses good TL response towards γ-rays as well as C5+ ion beam irradiation. TL glow curves of the C5+ ion irradiated phosphor show a small shift in the position of the glow peaks towards the lower temperature side. With an increase in energy of the ion beam increase in TL intensity was observed. This increase in the TL efficiency with a decrease in linear energy transfer (LET) agrees well with the results reported in literature. Trapping parameters of the γ-ray and C5+ ion beam irradiated phosphor were calculated from the TL data using computerized glow curve deconvolution method. The trapping analysis suggests that ion beam irradiation causes only minor changes in the activation energy. The different types of defects responsible for TL glow curves were identified using the EPR technique.
    Materials Chemistry and Physics 05/2015; 161. DOI:10.1016/j.matchemphys.2015.05.020 · 2.13 Impact Factor
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Particle irradiation started to draw attention in the past decade and has now become a hotspot in the radiation oncology community. This article reviews the most advanced developments in particle irradiation, focusing on the characteristics of proton and carbon ions in radiation physics and radiobiology. The Bragg peak of physical dose distribution causes proton and carbon beams to optimally meet the requirement for cancer irradiation because the Bragg peak permits the accurate concentration of the dose on the tumor, thus sparing the adjacent normal tissues. Moreover, carbon ion has more radiobiological benefits than photon and proton beams. These benefits include stronger sterilization effects on intrinsic radio-resistant tumors and more effective killing of hypoxic, G(0), and S phase cells. Compared with the most advanced radiation techniques using photon, such as three-dimensional conformal radiation therapy and intensity-modulated radiation therapy, proton therapy has yielded more promising outcomes in local control and survival for head and neck cancers, prostate carcinoma, and pediatric cancers. Carbon therapy in Japan showed even more promising results than proton therapy. The local controls and overall survivals were as good as that treated by surgery in early stages of non-small cell lung cancer, hepatocellular carcinoma, prostate carcinoma, and head and neck cancers, especially for such highly resistant tumors as melanoma. The non-invasive nature of particle therapy affords more patients with chances to receive and benefit from treatment. Particle therapy is gradually getting attention from the oncology community. However, the cost of particle therapy facilities has limited the worldwide use of this technology.
    05/2012; 6(2):165-72. DOI:10.1007/s11684-012-0196-4